Future Medicine (Drug Discovery) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $1.32M

  • Investors
  • 2

Future Medicine (Drug Discovery) General Information

Description

Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.

Contact Information

Website
www.futuremedicine.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 54 Changup-ro
  • Sujeong-gu
  • Seongnam, Gyeonggi 13449
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 54 Changup-ro
  • Sujeong-gu
  • Seongnam, Gyeonggi 13449
  • South Korea

Future Medicine (Drug Discovery) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Future Medicine (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. PIPE 31-Aug-2023 $1.32M Completed Generating Revenue
8. PIPE 16-Aug-2023 Completed Generating Revenue
7. PIPE 07-Apr-2023 Completed Generating Revenue
6. IPO 27-Jul-2022 Completed Clinical Trials - Phase 2
5. Later Stage VC 01-Feb-2021 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 01-Mar-2020 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B) 01-Apr-2019 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A) 01-Jul-2018 $5.56M $5.56M Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Startup
To view Future Medicine (Drug Discovery)’s complete valuation and funding history, request access »

Future Medicine (Drug Discovery) Patents

  • 116

    Total Documents Applications and Grants

  • Total Patents Families

  • 64

    Granted

  • 18

    Pending

  • Expiring in next 12 mo

Future Medicine (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023310068-A1 Ligand acting on adenosine receptors and composition comprising same for prevention, alleviation, or treatment of obesity Pending 22-Jul-2022
EP-4545081-A1 Ligand acting on adenosine receptors and composition comprising same for prevention, alleviation, or treatment of obesity Pending 22-Jul-2022
EP-4545081-A4 Ligand acting on adenosine receptors and composition comprising same for prevention, alleviation, or treatment of obesity Pending 22-Jul-2022
US-20260027121-A1 Ligand acting on adenosine receptors and composition comprising same for prevention, alleviation, or treatment of obesitys Pending 22-Jul-2022
JP-2025524713-A Ligand acting on adenosine receptors and composition containing same for preventing, ameliorating or treating obesity Pending 22-Jul-2022 A61K31/52
To view Future Medicine (Drug Discovery)’s complete patent history, request access »

Future Medicine (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Future Medicine (Drug Discovery) Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
LSK Investment Venture Capital Minority
BNB Asset Management Corporation Minority
To view Future Medicine (Drug Discovery)’s complete investors history, request access »

Ready to get started?

Request a free trial

Future Medicine (Drug Discovery) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Future Medicine (Drug Discovery)’s complete esg history, request access »

Future Medicine (Drug Discovery) FAQs

  • When was Future Medicine (Drug Discovery) founded?

    Future Medicine (Drug Discovery) was founded in 2015.

  • Where is Future Medicine (Drug Discovery) headquartered?

    Future Medicine (Drug Discovery) is headquartered in Seongnam, South Korea.

  • What is the size of Future Medicine (Drug Discovery)?

    Future Medicine (Drug Discovery) has 8 total employees.

  • What industry is Future Medicine (Drug Discovery) in?

    Future Medicine (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Future Medicine (Drug Discovery) a private or public company?

    Future Medicine (Drug Discovery) is a Private company.

  • What is Future Medicine (Drug Discovery)’s current revenue?

    The current revenue for Future Medicine (Drug Discovery) is .

  • How much funding has Future Medicine (Drug Discovery) raised over time?

    Future Medicine (Drug Discovery) has raised $30.4M.

  • Who are Future Medicine (Drug Discovery)’s investors?

    LSK Investment and BNB Asset Management have invested in Future Medicine (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process